from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3376/-

LFCtreatmentdescriptionclass of inhibitor

0.899

Amikacinug/mL Amikacintranslation

1.068

Cap5-10ug/mL Capreomycintranslation

1.275

Rox10-50 ug/mL Roxithromycintranslation

-0.326

SM2-5 ug/mL Streptomycintranslation

0.309

Tet5-10 ug/mL Tetracyclinetranslation

0.056

Rif0.2-5ug/mL Rifampicintranscription

-0.208

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.619

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.540

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.431

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.715

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.305

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.800

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.181

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.560

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.159

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.302

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.075

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.575

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.521

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.687

KCN5-20 ug/mL Potassium cyaniderespiration

0.570

NaN30.2-2 mM Sodium aziderespiration

0.293

Nigericin50 uM Nigericinrespiration

-0.889

TRC10-150 ug/mL Triclosanrespiration

-1.549

TRZ10-25 ug/mL Thioridazinerespiration

0.671

Valinomycin0.5-10 uM Valinomycinrespiration

-0.848

ZnSO42 mM ZnSO4respiration

1.031

menadione6-10 ug/mL Menadionerespiration

-0.756

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.366

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.292

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.124

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.686

NRP_1Non-replicating persistence stage 1dosRassociated

0.467

Amp0.2mg/mL AmpicillincellWall

-0.669

Cephalexin20-100 ug/mL CephalexincellWall

-0.106

Cerulenin0.32-5 ug/mL CerulenincellWall

0.263

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.363

EMB10-20 ug/mL EthambutolcellWall

-1.141

Eta12-40 ug/mL EthionamidecellWall

-0.914

INH0.2-0.4 ug/mL IsoniazidcellWall

0.297

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.021

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.152

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.618

BZA0.12 mg/mL BenzamidearomaticAmides

-0.013

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.057

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.185

H2O24 mM hydrogen peroxideDNAdamaging

0.224

Levo10 ug/mL LevofloxacinDNAdamaging

0.449

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.186

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.860

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.912

UVUV-irradiationDNAdamaging

-0.662

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.505

Antimycin12.5-50 ug/mL Antimycin A?

0.315

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.216

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.296

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.683

PA8240.2-2 ug/mL PA-824?

0.362

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.436

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.229

Verapamil50 uM Verapamil?

0.835

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.339

methoxatin10-20 ug/mL Methoxatin?